Question 70

Wegovy is indicated to help manage obesity.

Wegovy is specifically approved for the treatment of obesity, assisting in weight management and reduction in individuals with a body mass index (BMI) of 30 or greater, or 27 or greater with associated conditions.

A) diverticulitis

Diverticulitis pertains to the inflammation of pouches that can form in the intestines, which is unrelated to weight management. Wegovy does not have any indications for treating gastrointestinal conditions such as diverticulitis.

B) overactive bladder

An overactive bladder is a condition characterized by an urgent need to urinate frequently. Wegovy does not address urinary issues, making this option incorrect in relation to its indication for weight management.

C) depression

While depression is a serious mental health condition, Wegovy is not indicated for its treatment. This medication focuses on weight loss rather than mental health disorders, thus rendering this option incorrect.

D) obesity

Wegovy is explicitly indicated for the management of obesity. It is designed to aid in weight loss for individuals struggling with obesity, making this option the correct answer.

Conclusion

Wegovy's primary indication for managing obesity clearly distinguishes it from the other options, which pertain to unrelated medical conditions. As the correct choice, D emphasizes the medication's role in promoting weight loss, while A, B, and C fail to align with Wegovy's therapeutic purpose.